Records containing: Sickle Cell Disease

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2020-09-24
Pilot Study Examining Mechanisms of Iron Trafficking and Extra-hepatic Iron Distribution in Sickle Cell Disease, Thalassemia, and Other Iron Loading Anemias
CLINICAL_TRIALS study record update · 2020-09-23
Modulation of Iron Deposition in Sickle Cell Disease and Other Hemoglobinopathies SURVEY STUDY
CLINICAL_TRIALS study record update · 2020-09-11
Mechanistic Study: Non-Invasive Cutaneous Microvascular and Fibrosis Imaging of Patients With Systemic Sclerosis, Sickle Cell Disease and Chronic Graft-Versus-Host Disease (GVHD) Compared to Healthy Subjects
CLINICAL_TRIALS study record update · 2020-09-10
Niacin Therapy to Improve Endothelial Function in Sickle Cell Disease
CLINICAL_TRIALS study record update · 2020-09-01
Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2020-08-18
Cannabinoid-Based Therapy and Approaches to Quantify Pain in Sickle Cell Disease
CLINICAL_TRIALS study record update · 2020-08-03
Primary Prevention of Strokes in Nigerian Children With Sickle Cell Disease Affiliated Titles: Sickle Cell Disease - Stroke Prevention in Nigeria (SPIN) Trial
CLINICAL_TRIALS study record update · 2020-08-03
Primary Prevention of Stroke in Children With Sickle Cell Disease in Sub-Saharan Africa II
CLINICAL_TRIALS study record update · 2020-07-31
Allogeneic Bone Marrow Transplantation From HLA Identical Related Donors for Patients With Hemoglobinopathies: Hemoglobin SS, Hemoglobin SC, or Hemoglobin SB0/+ Thalassemia
CLINICAL_TRIALS study record update · 2020-07-30
Pharmacokinetic and Pharmacodynamic Study of Ilera Medical Marijuana Products
CLINICAL_TRIALS study record update · 2020-07-29
Safety and Feasibility of High-Dose Topical Capsaicin for the Treatment of Neuropathic Pain in Pediatric Sickle Cell Disease
CLINICAL_TRIALS study record update · 2020-07-28
Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease
CLINICAL_TRIALS study record update · 2020-07-15
A Randomised, Double Blind, Parallel Group, Multicentre, Phase III Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing the Number of Vaso-Occlusive Crises in Paediatric Patients Aged 6 Months to <18 Years With Sickle Cell Disease (HESTIA5)
CLINICAL_TRIALS study record update · 2020-07-10
Quantitative and Prognostic Evaluation of Dense Red Blood Cells in Sickle Cell Children: Single-center Study From the Creteil (France) Pediatric Cohort
CLINICAL_TRIALS study record update · 2020-07-09
A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease
CLINICAL_TRIALS study record update · 2020-07-07
Randomized Trial of High-dose Intravenous Methylprednisolone and Steroid Taper for Vaso-occlusive Crises in Sickle Cell Disease
CLINICAL_TRIALS study record update · 2020-05-13
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of GMI-1070, A Pan-Selectin Inhibitor, In Subjects Hospitalized For Sickle Cell Vaso-Occlusive Crisis
CLINICAL_TRIALS study record update · 2020-04-20
Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients Using Plerixafor
CLINICAL_TRIALS study record update · 2020-04-16
Self-Management for Youth and Families Living With Sickle Cell Disease - SMYLS
CLINICAL_TRIALS study record update · 2020-03-27
Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina
CLINICAL_TRIALS study record update · 2020-03-23
Vitamin D Intervention in Children With Sickle Cell Disease: A Pilot Randomized Controlled Trial
CLINICAL_TRIALS study record update · 2020-03-19
ESCORT-HU : European Sickle Cell Disease Cohort - Hydroxyurea
CLINICAL_TRIALS study record update · 2020-03-11
Impact of Daily Prophylaxis Dose Anticoagulation With a Factor Xa Inhibitor (Apixaban) in Patients With Sickle Cell Disease
CLINICAL_TRIALS study record update · 2020-03-10
A Phase 1/2 Open Label Study Evaluating the Safety and Efficacy of Gene Therapy of the β-Hemoglobinopathies (Sickle Cell Anemia and β-Thalassemia Major) by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With a Lentiviral β-A-T87Q Globin Vector (LentiGlobin BB305 Drug Product)
CLINICAL_TRIALS study record update · 2020-02-20
Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study